Pharmacology of Antiarrhythmics and Antihypertensives

1. THE PHYSIOLOGICAL FOUNDATION

• Antiarrhythmics: These agents terminate dysrhythmias by modifying autonomic function or blocking specific myocardial ion channels, thereby altering conduction velocity and the effective refractory period (ERP). They are classically organized by the Vaughan-Williams system (External Knowledge):
• Class I (Na-channel blockers): Slow phase 0 depolarization.
• Class II (Beta-blockers): Suppress AV/SA node automaticity.
• Class III (K-channel blockers): Prolong repolarization and the ERP.
• Class IV (Ca-channel blockers): Slow phase 4 spontaneous depolarization and AV nodal conduction.
• Antihypertensives: In a hypertensive emergency, the physiological goal is to reverse acute end-organ damage (brain, heart, kidneys, aorta) without precipitating ischemic steal. The body's autoregulatory curve shifts rightward in chronic hypertension; abrupt normalization of blood pressure can severely hypoperfuse vital organs.

2. THE MATHEMATICAL / DIAGNOSTIC ENGINE

• QRS Duration Cutoffs:
• Narrow-Complex: < 0.12 seconds in adults; \(\le\) 0.09 seconds in pediatrics. Primarily represents sinus tachycardia or supraventricular tachycardia (SVT).
• Wide-Complex: \(\ge\) 0.12 seconds. Must be presumed to be Ventricular Tachycardia (VT) or SVT with aberrant conduction.
• Hypertensive Emergency Criteria: SBP >180 mm Hg and/or DBP >120 mm Hg with acute ongoing end-organ damage (e.g., ACS, aortic dissection, encephalopathy, acute renal failure).
• Blood Pressure Reduction Mathematics:
• Standard Emergency: Lower MAP by 10%–20% (up to 25%) in the first hour, followed by a 5%–15% drop over the next 23 hours.
• Aortic Dissection Exception: SBP strictly lowered to 100–120 mm Hg within 20 minutes.
• Ischemic Stroke Exception: Do not lower BP unless >185/110 mm Hg (if tPA candidate) or >220/120 mm Hg (if not a tPA candidate).

3. THE CRASHING PATIENT PROTOCOL

Management is strictly driven by the presence of hemodynamic instability (hypotension, AMS, signs of shock, ischemic chest pain, or acute heart failure).

• Unstable Tachycardia: Skip pharmacologic conversion. Proceed immediately to synchronized cardioversion (sedate if feasible, but do not delay).
• Unstable Bradycardia:
• Administer Atropine 1 mg IV bolus (repeat every 3-5 mins, max 3 mg).
• If ineffective, rapidly transition to Transcutaneous Pacing OR start an Epinephrine infusion (2–10 mcg/min) or Dopamine infusion (5–20 mcg/kg/min).
• Crashing Hypertensive Acute Heart Failure: Initiate Non-Invasive Positive Pressure Ventilation (NIPPV) and aggressive vasodilation to decrease afterload. Target a \(\sim\) 25% drop in SBP utilizing sublingual Nitroglycerin (0.4 mg x1-5) or high-dose IV Nitroglycerin infusion.

4. THE PHARMACOLOGY MATRIX

• Adenosine (Antiarrhythmic)
• Target: Purinergic receptors (transiently blocks AV node conduction) (External Knowledge).
• Dose: 6 mg rapid IV push with a saline flush. Second dose: 12 mg.
• Indication: Regular, monomorphic narrow-complex tachycardias.
• Amiodarone (Class III Antiarrhythmic)
• Target: K-channel blocker (with Class I, II, and IV properties) (External Knowledge).
• Dose: 150 mg IV over 10 minutes. Maintenance infusion: 1 mg/min for the first 6 hours.
• Procainamide (Class Ia Antiarrhythmic)
• Target: Na-channel blocker (External Knowledge).
• Dose: 20–50 mg/min infusion. Maintenance: 1-4 mg/min.
• Labetalol (Antihypertensive)
• Target: Combined alpha-1 and non-selective beta-blocker (External Knowledge).
• Dose: 10-20 mg IV bolus over 2 mins, repeat every 10-20 minutes with escalating doses (20, 40, 80 mg) up to 200 mg cumulative.
• Diltiazem (Class IV Antiarrhythmic / Antihypertensive)
• Target: Calcium channel blocker.
• Dose: 15–20 mg IV bolus over 2 mins. Maintenance infusion: 5–10 mg/h (titrated to HR <90-100).

5. THE TITRATION & MONITORING GRID

• Procainamide Stop-Points: When administering a Procainamide infusion for stable VT, you must stop the infusion immediately if: 1) The arrhythmia is suppressed, 2) Hypotension ensues, 3) The QRS duration increases by >50%, or 4) The maximum dose of 17 mg/kg is reached.
• Atropine Monitoring: Atropine is a vagolytic agent. It will effectively treat sinus bradycardia or first-degree blocks but will reliably fail in non-parasympathetic causes, such as wide-complex third-degree heart blocks or Mobitz II blocks (External Knowledge). Prepare the pacer pads.

6. THE DANGER ZONE

• The "Double Antiarrhythmic" Trap: Giving Amiodarone and Procainamide sequentially to a patient with stable wide-complex tachycardia. Both agents significantly increase the QRS and QTc intervals. Giving both risks catastrophic cardiovascular collapse or precipitating Torsades de Pointes.
• The "Sublingual Nifedipine" Clean Kill: Administering sublingual nifedipine for a hypertensive emergency is highly dangerous and explicitly contraindicated, as it causes unpredictable, precipitous drops in blood pressure leading to acute cerebral or myocardial ischemia.
• The Pediatric Verapamil Trap: Administering IV Verapamil to an infant/toddler (< 2 years old) for SVT. It causes profound myocardial depression, intractable hypotension, and cardiac arrest.

7. MCQ MASTERCLASS

• The "Torsades" Formula: A board question will present a polymorphic VT "twisting around the isoelectric line." Crucially, polymorphic VT without a prolonged QT is driven by cardiac ischemia. Polymorphic VT with a prolonged QT is true Torsades de Pointes. The immediate treatment is IV Magnesium Sulfate (2 g over 15 mins).
• The "Rate-Controlled but Crashing" Distractor: If a patient with SVT at 180 bpm is hypotensive (e.g., 70/40 mm Hg) or altered, distractors will offer Adenosine or Diltiazem. The correct board answer is always immediate Synchronized Cardioversion for the unstable patient.
• The "Right-Sided STEMI" Trap: In a patient presenting with an inferior STEMI and concurrent right ventricular infarction (diagnosed via V4R), administering Nitroglycerin (a preload reducer) will precipitate severe, refractory hypotension (External Knowledge).

8. THE ER RESIDENCY SCRIPT

"Cardiology/ICU team, I am consulting you for a 65-year-old male presenting with a hypertensive emergency complicated by acute cardiogenic pulmonary edema. Upon arrival, his BP was 225/130 with significant respiratory distress, hypoxia, and flash pulmonary edema on POCUS. He was placed on NIPPV and we initiated a high-dose IV Nitroglycerin infusion to reduce preload and afterload, strictly targeting a 25% reduction in his SBP to roughly 160 mm Hg over this first hour to prevent ischemic steal. His respiratory status is improving, and his SBP is now 165 mm Hg. His ECG shows LVH with strain but no acute ischemic changes, and his troponin is pending. He requires admission to the CCU for continuous arterial blood pressure monitoring and gradual transition to oral antihypertensives as his respiratory failure resolves."